Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System

Contributed by: PR Newswire

Tags

EndoToolsTherapeutics

More Like This

PR Newswire associated0

Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation endomina® EZFuse system

Endo Tools Therapeutics Appoints Devon Bream as Chief Executive Officer

Nitinotes Expands European Commercial Adoption with First Commercial EndoZip™ Cases Performed in France

Nitinotes Announces First Commercial EndoZip™ Procedures in Spain

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Nitinotes Announces FDA IDE Approval to Initiate Pivotal U.S. Trial of the EndoZip™ System for Endoscopic Sleeve Gastroplasty

ACCESSWIRE associated3

Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure

PR Newswire associated0

Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy